Treatment with mesenchymal stem cells reprograms fibrotic liver tissue via miRNA cargo delivery
Mesenchymal stem cell (MSC) therapy shows promise in liver fibrosis treatment. This article analyzes how MSCs, acting as miRNA delivery vehicles, reprogram fibrotic liver tissue, offering a novel therapeutic approach with potential for significant clinical impact. Learn more about the mechanisms involved.